Crystal Fredrickson, PA
Medical · Edmond, OKNPI 1649329996
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.1% of the total across 252 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations.
Across 252 payments — averaging $19.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$794
- Regeneron Healthcare Solutions, Inc.$575
- Johnson & Johnson$567
- Pfizer$526
- LEO Pharma Inc.$445
- Sanofi$378
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,73494%
- Education$2956%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 51 | $794 |
| Regeneron Healthcare Solutions, Inc. | 19 | $575 |
| Johnson & Johnson | 18 | $567 |
| Pfizer | 31 | $526 |
| LEO Pharma Inc. | 20 | $445 |
| Sanofi | 14 | $378 |
| Sun Pharmaceutical Industries Inc. | 14 | $327 |
| Lilly USA, LLC | 16 | $318 |
| Arcutis Biotherapeutics, Inc. | 25 | $199 |
| E.r. Squibb & Sons, L.L.C. | 3 | $145 |
| Amgen | 5 | $115 |
| UCB, Inc. | 4 | $97 |
| AbbVie | 4 | $86 |
| Mayne Pharma Commercial LLC | 6 | $84 |
| Galderma Laboratories, L.p. | 5 | $77 |
| VYNE Pharmaceuticals Inc. | 4 | $64 |
| Organogenesis Inc. | 2 | $54 |
| Verrica Pharmaceuticals Inc. | 2 | $36 |
| Boehringer Ingelheim | 1 | $27 |
| Blueprint Medicines Corporation | 1 | $27 |
| Nabriva Therapeutics, PLC | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Botanix SB Inc | 1 | $18 |
| Incyte Corporation | 1 | $18 |
| Organon | 3 | $12 |
How this compares
$5,029 in reported general payments places this provider in the 85th percentile of 370 medical providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 35 | $1,895 |
| Ketoconazole | 58 | $1,621 |
| Fluorouracil | 21 | $1,530 |
| Clindamycin Phosphate | 49 | $1,327 |
| Fluocinonide | 21 | $671 |
| Metronidazole | 11 | $444 |
| Hydrocortisone | 35 | $415 |
| Doxycycline Hyclate | 24 | $393 |
| Betamethasone Dipropionate | 12 | $370 |
| Triamcinolone Acetonide | 44 | $240 |
| Imiquimod | 11 | $227 |
| Mupirocin | 13 | $91 |
| ValacyclovirValacyclovir Hcl | 14 | $87 |
| Spironolactone | 15 | $64 |
| Cephalexin | 20 | $41 |
Paid to pharmacies, not to this prescriber.
Other medical in Edmond
- Elizabeth MontgomeryEdmond$9K
- Amelia MonchoEdmond$7K
- Amber WellmanEdmond$5K
- Bethany TrianaEdmond$4K
- Shannon MedleyEdmond$3K
- Karlee PfaffEdmond$3K
- Mebin ThomasOklahoma City$323K
- Kelle ChristiansonMidwest City$117K
- Kristine MurrowOklahoma City$81K
- Matthew DohlmanTulsa$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.